Estazolam and Flurazepam: A Multicenter, Placebo-Controlled Comparative Study in Outpatients with Insomnia
- 1 May 1990
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 30 (5), 461-467
- https://doi.org/10.1002/j.1552-4604.1990.tb03486.x
Abstract
A multicenter, double‐blind placebo‐controlled clinical trial was designed to compare the safety and efficacy of estazolam compared with flurazepam as hypnotics. Outpatients complaining of insomnia were randomized to receive either estazolam 2 mg, flurazepam 30 mg or placebo for 7 consecutive nights. The analysis of efficacy was based on the patients' daily assessments of sleep and the investigators' global evaluations. Adverse events which were considered by the investigator to be attributable to, or of unknown relationship to the test medication were analyzed. The patient subjective questionnaire indicated that estazolam and flurazepam signiflcantly improved all parameters (P < .05) as compared to placebo. A marked or moderate improvement in sleep was reported by 81% (58/72), 78% (63/81) and 36% (27/76) of estazolam, flurazepam, and placebo recipients, respectively. There were no significant differences in hypnotic effect between estazolam and flurazepam. All efficacy parameters of the investigators' global evaluation improved signiflcantly more (P < .05) for patients receiving estazolam or flurazepam (except quality of sleep) than for those receiving placebo. The percentage of patients reporting any adverse experience was greatest for flurazepam (72%), followed by estazolam (59%), and placebo (43%). Somnolence and hypokinesia were the most commonly reported adverse events. An analysis of the global evaluation of side effects showed that flurazepam had a significantly worse side effect profile than estazolam (P < .05) or placebo (P = .001). Estazolam and flurazepam effectively, and comparably, relieved insomnia when administered for 7 nights in adult patients complaining of insomnia. Estazolam demonstrated a more favorable side effect profile than flurazepam.Keywords
This publication has 9 references indexed in Scilit:
- Effect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of TriazolamThe New England Journal of Medicine, 1987
- The clinical use of hypnotics: indications for use and the need for a variety of hypnoticsActa Psychiatrica Scandinavica, 1986
- Metabolism of14C-estazolam in dogs and humansXenobiotica, 1986
- Insomnia and Its TreatmentArchives of General Psychiatry, 1985
- Triazolam and Anterograde AmnesiaJournal of Clinical Psychopharmacology, 1983
- Current Status of BenzodiazepinesThe New England Journal of Medicine, 1983
- Early Morning Insomnia with Rapidly Eliminated BenzodiazepinesScience, 1983
- Evaluation of Temazepam as a HypnoticPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1981
- The effects of flurazepam, lorazepam, and triazolam on sleep and memoryPsychopharmacology, 1980